Oncology Cancer Drugs Market Report

1 Report Overview

• 1.1 Product Definition and Scope

• 1.2 PEST (Political, Economic, Social and Technological) Analysis of Oncology Cancer Drugs Market

• 1.3 Market Segment by Type

• 1.3.1 Japan Oncology Cancer Drugs Market Size and Growth Rate of Blood Cancer from 2014 to 2026

• 1.3.2 Japan Oncology Cancer Drugs Market Size and Growth Rate of Breast Cancer from 2014 to 2026

• 1.3.3 Japan Oncology Cancer Drugs Market Size and Growth Rate of Gastrointestinal Cancer from 2014 to 2026

• 1.3.4 Japan Oncology Cancer Drugs Market Size and Growth Rate of Prostate Cancer from 2014 to 2026

• 1.3.5 Japan Oncology Cancer Drugs Market Size and Growth Rate of Others from 2014 to 2026

• 1.4 Market Segment by Application

• 1.4.1 Japan Oncology Cancer Drugs Market Size and Growth Rate of Chemotherapy from 2014 to 2026

• 1.4.2 Japan Oncology Cancer Drugs Market Size and Growth Rate of Targeted Therapy from 2014 to 2026

• 1.4.3 Japan Oncology Cancer Drugs Market Size and Growth Rate of Immunotherapy (Biologic Therapy) from 2014 to 2026

• 1.4.4 Japan Oncology Cancer Drugs Market Size and Growth Rate of Hormonal Therapy from 2014 to 2026

• 1.4.5 Japan Oncology Cancer Drugs Market Size and Growth Rate of Others from 2014 to 2026

• 1.5 Market Segment by Regions

• 1.5.1 Hokkaido Oncology Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.2 Tohoku Oncology Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.3 Kanto Oncology Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.4 Chubu Oncology Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.5 Kinki Oncology Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.6 Chugoku Oncology Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.7 Shikoku Oncology Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.8 Kyushu Oncology Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

• 2.1 Market Trends and Dynamics

• 2.1.1 Market Challenges and Restraints

• 2.1.2 Market Opportunities and Potentials

• 2.1.3 Mergers and Acquisitions

• 2.2 Competitive Landscape Analysis

• 2.2.1 Industrial Concentration Analysis

• 2.2.2 Porter's Five Forces Analysis of the Industry

• 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Oncology Cancer Drugs Market by Types

• 3.1 Products Development Trends of Different Types

• 3.2 Commercial Products Types of Major Vendors

• 3.3 Competitive Landscape Analysis of Different Types

• 3.4 Market Size of Oncology Cancer Drugs by Major Types

• 3.4.1 Market Size and Growth Rate of Blood Cancer

• 3.4.2 Market Size and Growth Rate of Breast Cancer

• 3.4.3 Market Size and Growth Rate of Gastrointestinal Cancer

• 3.4.4 Market Size and Growth Rate of Prostate Cancer

• 3.4.5 Market Size and Growth Rate of Others

4 Segmentation of Oncology Cancer Drugs Market by End-Users

• 4.1 Downstream Client Analysis by End-Users

• 4.2 Competitive Landscape Analysis of Different End-Users

• 4.3 Market Potential Analysis of Different End-Users

• 4.4 Market Size of Oncology Cancer Drugs by Major End-Users

• 4.4.1 Market Size and Growth Rate of Oncology Cancer Drugs in Chemotherapy

• 4.4.2 Market Size and Growth Rate of Oncology Cancer Drugs in Targeted Therapy

• 4.4.3 Market Size and Growth Rate of Oncology Cancer Drugs in Immunotherapy (Biologic Therapy)

• 4.4.4 Market Size and Growth Rate of Oncology Cancer Drugs in Hormonal Therapy

• 4.4.5 Market Size and Growth Rate of Oncology Cancer Drugs in Others

5 Market Analysis by Regions

• 5.1 Japan Oncology Cancer Drugs Production Analysis by Regions

• 5.2 Japan Oncology Cancer Drugs Consumption Analysis by Regions

6 Hokkaido Oncology Cancer Drugs Landscape Analysis

• 6.1 Hokkaido Oncology Cancer Drugs Landscape Analysis by Major Types

• 6.2 Hokkaido Oncology Cancer Drugs Landscape Analysis by Major End-Users

7 Tohoku Oncology Cancer Drugs Landscape Analysis

• 7.1 Tohoku Oncology Cancer Drugs Landscape Analysis by Major Types

• 7.2 Tohoku Oncology Cancer Drugs Landscape Analysis by Major End-Users

8 Kanto Oncology Cancer Drugs Landscape Analysis

• 8.1 Kanto Oncology Cancer Drugs Landscape Analysis by Major Types

• 8.2 Kanto Oncology Cancer Drugs Landscape Analysis by Major End-Users

9 Chubu Oncology Cancer Drugs Landscape Analysis

• 9.1 Chubu Oncology Cancer Drugs Landscape Analysis by Major Types

• 9.2 Chubu Oncology Cancer Drugs Landscape Analysis by Major End-Users

10 Kinki Oncology Cancer Drugs Landscape Analysis

• 10.1 Kinki Oncology Cancer Drugs Landscape Analysis by Major Types

• 10.2 Kinki Oncology Cancer Drugs Landscape Analysis by Major End-Users

11 Chugoku Oncology Cancer Drugs Landscape Analysis

• 11.1 Chugoku Oncology Cancer Drugs Landscape Analysis by Major Types

• 11.2 Chugoku Oncology Cancer Drugs Landscape Analysis by Major End-Users

12 Shikoku Oncology Cancer Drugs Landscape Analysis

• 12.1 Shikoku Oncology Cancer Drugs Landscape Analysis by Major Types

• 12.2 Shikoku Oncology Cancer Drugs Landscape Analysis by Major End-Users

13 Kyushu Oncology Cancer Drugs Landscape Analysis

• 13.1 Kyushu Oncology Cancer Drugs Landscape Analysis by Major Types

• 13.2 Kyushu Oncology Cancer Drugs Landscape Analysis by Major End-Users

14 Major Players Profiles

• 14.1 Roche diagnostics
  

• 14.1.1 Roche diagnostics Company Profile and Recent Development

• 14.1.2 Market Performance

• 14.1.3 Product and Service Introduction

• 14.2 GlaxoSmithKline
  

• 14.2.1 GlaxoSmithKline Company Profile and Recent Development

• 14.2.2 Market Performance

• 14.2.3 Product and Service Introduction

• 14.3 Johnson & Johnson
  

• 14.3.1 Johnson & Johnson Company Profile and Recent Development

• 14.3.2 Market Performance

• 14.3.3 Product and Service Introduction

• 14.4 Eli lilly
  

• 14.4.1 Eli lilly Company Profile and Recent Development

• 14.4.2 Market Performance

• 14.4.3 Product and Service Introduction

• 14.5 Celgene
  

• 14.5.1 Celgene Company Profile and Recent Development

• 14.5.2 Market Performance

• 14.5.3 Product and Service Introduction

• 14.6 Novartis
  

• 14.6.1 Novartis Company Profile and Recent Development

• 14.6.2 Market Performance

• 14.6.3 Product and Service Introduction

• 14.7 Sanofi
  

• 14.7.1 Sanofi Company Profile and Recent Development

• 14.7.2 Market Performance

• 14.7.3 Product and Service Introduction

• 14.8 Merck
  

• 14.8.1 Merck Company Profile and Recent Development

• 14.8.2 Market Performance

• 14.8.3 Product and Service Introduction

• 14.9 Pfizer & Co
  

• 14.9.1 Pfizer & Co Company Profile and Recent Development

• 14.9.2 Market Performance

• 14.9.3 Product and Service Introduction

• 14.10 Celgene & Co.
  

• 14.10.1 Celgene & Co. Company Profile and Recent Development

• 14.10.2 Market Performance

• 14.10.3 Product and Service Introduction

The List of Tables and Figures (Totals 126 Figures and 186 Tables)

• Figure Japan Oncology Cancer Drugs Market Size and Growth Rate of Blood Cancer from 2014 to 2026

• Figure Japan Oncology Cancer Drugs Market Size and Growth Rate of Breast Cancer from 2014 to 2026

• Figure Japan Oncology Cancer Drugs Market Size and Growth Rate of Gastrointestinal Cancer from 2014 to 2026

• Figure Japan Oncology Cancer Drugs Market Size and Growth Rate of Prostate Cancer from 2014 to 2026

• Figure Japan Oncology Cancer Drugs Market Size and Growth Rate of Others from 2014 to 2026

• Figure Market Share by Type in 2014

• Figure Market Share by Type in 2018

• Figure Market Share by Type in 2026

• Figure Japan Oncology Cancer Drugs Market Size and Growth Rate of Chemotherapy from 2014 to 2026

• Figure Japan Oncology Cancer Drugs Market Size and Growth Rate of Targeted Therapy from 2014 to 2026

• Figure Japan Oncology Cancer Drugs Market Size and Growth Rate of Immunotherapy (Biologic Therapy) from 2014 to 2026

• Figure Japan Oncology Cancer Drugs Market Size and Growth Rate of Hormonal Therapy from 2014 to 2026

• Figure Japan Oncology Cancer Drugs Market Size and Growth Rate of Others from 2014 to 2026

• Figure Market Share by End-User in 2014

• Figure Market Share by End-User in 2018

• Figure Market Share by End-User in 2026

• Figure Hokkaido Oncology Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Tohoku Oncology Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Kanto Oncology Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Chubu Oncology Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Kinki Oncology Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Chugoku Oncology Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Shikoku Oncology Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Kyushu Oncology Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Development Trends and Industry Dynamics of Oncology Cancer Drugs Industry

• Figure Market Challenges and Restraints

• Figure Market Opportunities and Potentials

• Table Mergers and Acquisition

• Figure Market Share of TOP 3 Players in 2018

• Figure Market Share of TOP 5 Players in 2018

• Figure Market Share of TOP 6 Players from 2014 to 2019

• Figure Porter's Five Forces Analysis

• Figure New Entrant SWOT Analysis

• Table Specifications of Different Types of Oncology Cancer Drugs

• Figure Development Trends of Different Types

• Table Commercial Products Types of Major Vendors

• Figure Competitive Landscape Analysis of Different Types

• Table Consumption of Oncology Cancer Drugs by Different Types from 2014 to 2026

• Table Consumption Share of Oncology Cancer Drugs by Different Types from 2014 to 2026

• Figure Market Size and Growth Rate of Blood Cancer

• Figure Market Size and Growth Rate of Breast Cancer

• Figure Market Size and Growth Rate of Gastrointestinal Cancer

• Figure Market Size and Growth Rate of Prostate Cancer

• Figure Market Size and Growth Rate of Others

• Table Downstream Client Analysis by End-Users

• Figure Competitive Landscape Analysis of Different End-Users

• Table Market Potential Analysis of Different End-Users

• Table Consumption of Oncology Cancer Drugs by Different End-Users from 2014 to 2026

• Table Consumption Share of Oncology Cancer Drugs by Different End-Users from 2014 to 2026

• Figure Japan Oncology Cancer Drugs Market Size and Growth Rate of Chemotherapy from 2014 to 2026

• Figure Japan Oncology Cancer Drugs Market Size and Growth Rate of Targeted Therapy from 2014 to 2026

• Figure Japan Oncology Cancer Drugs Market Size and Growth Rate of Immunotherapy (Biologic Therapy) from 2014 to 2026

• Figure Japan Oncology Cancer Drugs Market Size and Growth Rate of Hormonal Therapy from 2014 to 2026

• Figure Japan Oncology Cancer Drugs Market Size and Growth Rate of Others from 2014 to 2026

• Table Japan Oncology Cancer Drugs Production by Regions

• Table Japan Oncology Cancer Drugs Production Share by Regions

• Figure Japan Oncology Cancer Drugs Production Share by Regions in 2014

• Figure Japan Oncology Cancer Drugs Production Share by Regions in 2018

• Figure Japan Oncology Cancer Drugs Production Share by Regions in 2026

• Table Japan Oncology Cancer Drugs Consumption by Regions

• Table Japan Oncology Cancer Drugs Consumption Share by Regions

• Figure Japan Oncology Cancer Drugs Consumption Share by Regions in 2014

• Figure Japan Oncology Cancer Drugs Consumption Share by Regions in 2018

• Figure Japan Oncology Cancer Drugs Consumption Share by Regions in 2026

• Table Hokkaido Oncology Cancer Drugs Consumption by Types from 2014 to 2026

• Table Hokkaido Oncology Cancer Drugs Consumption Share by Types from 2014 to 2026

• Figure Hokkaido Oncology Cancer Drugs Consumption Share by Types in 2014

• Figure Hokkaido Oncology Cancer Drugs Consumption Share by Types in 2018

• Figure Hokkaido Oncology Cancer Drugs Consumption Share by Types in 2026

• Table Hokkaido Oncology Cancer Drugs Consumption by End-Users from 2014 to 2026

• Table Hokkaido Oncology Cancer Drugs Consumption Share by End-Users from 2014 to 2026

• Figure Hokkaido Oncology Cancer Drugs Consumption Share by End-Users in 2014

• Figure Hokkaido Oncology Cancer Drugs Consumption Share by End-Users in 2018

• Figure Hokkaido Oncology Cancer Drugs Consumption Share by End-Users in 2026

• Table Tohoku Oncology Cancer Drugs Consumption by Types from 2014 to 2026

• Table Tohoku Oncology Cancer Drugs Consumption Share by Types from 2014 to 2026

• Figure Tohoku Oncology Cancer Drugs Consumption Share by Types in 2014

• Figure Tohoku Oncology Cancer Drugs Consumption Share by Types in 2018

• Figure Tohoku Oncology Cancer Drugs Consumption Share by Types in 2026

• Table Tohoku Oncology Cancer Drugs Consumption by End-Users from 2014 to 2026

• Table Tohoku Oncology Cancer Drugs Consumption Share by End-Users from 2014 to 2026

• Figure Tohoku Oncology Cancer Drugs Consumption Share by End-Users in 2014

• Figure Tohoku Oncology Cancer Drugs Consumption Share by End-Users in 2018

• Figure Tohoku Oncology Cancer Drugs Consumption Share by End-Users in 2026

• Table Kanto Oncology Cancer Drugs Consumption by Types from 2014 to 2026

• Table Kanto Oncology Cancer Drugs Consumption Share by Types from 2014 to 2026

• Figure Kanto Oncology Cancer Drugs Consumption Share by Types in 2014

• Figure Kanto Oncology Cancer Drugs Consumption Share by Types in 2018

• Figure Kanto Oncology Cancer Drugs Consumption Share by Types in 2026

• Table Kanto Oncology Cancer Drugs Consumption by End-Users from 2014 to 2026

• Table Kanto Oncology Cancer Drugs Consumption Share by End-Users from 2014 to 2026

• Figure Kanto Oncology Cancer Drugs Consumption Share by End-Users in 2014

• Figure Kanto Oncology Cancer Drugs Consumption Share by End-Users in 2018

• Figure Kanto Oncology Cancer Drugs Consumption Share by End-Users in 2026

• Table Chubu Oncology Cancer Drugs Consumption by Types from 2014 to 2026

• Table Chubu Oncology Cancer Drugs Consumption Share by Types from 2014 to 2026

• Figure Chubu Oncology Cancer Drugs Consumption Share by Types in 2014

• Figure Chubu Oncology Cancer Drugs Consumption Share by Types in 2018

• Figure Chubu Oncology Cancer Drugs Consumption Share by Types in 2026

• Table Chubu Oncology Cancer Drugs Consumption by End-Users from 2014 to 2026

• Table Chubu Oncology Cancer Drugs Consumption Share by End-Users from 2014 to 2026

• Figure Chubu Oncology Cancer Drugs Consumption Share by End-Users in 2014

• Figure Chubu Oncology Cancer Drugs Consumption Share by End-Users in 2018

• Figure Chubu Oncology Cancer Drugs Consumption Share by End-Users in 2026

• Table Kinki Oncology Cancer Drugs Consumption by Types from 2014 to 2026

• Table Kinki Oncology Cancer Drugs Consumption Share by Types from 2014 to 2026

• Figure Kinki Oncology Cancer Drugs Consumption Share by Types in 2014

• Figure Kinki Oncology Cancer Drugs Consumption Share by Types in 2018

• Figure Kinki Oncology Cancer Drugs Consumption Share by Types in 2026

• Table Kinki Oncology Cancer Drugs Consumption by End-Users from 2014 to 2026

• Table Kinki Oncology Cancer Drugs Consumption Share by End-Users from 2014 to 2026

• Figure Kinki Oncology Cancer Drugs Consumption Share by End-Users in 2014

• Figure Kinki Oncology Cancer Drugs Consumption Share by End-Users in 2018

• Figure Kinki Oncology Cancer Drugs Consumption Share by End-Users in 2026

• Table Chugoku Oncology Cancer Drugs Consumption by Types from 2014 to 2026

• Table Chugoku Oncology Cancer Drugs Consumption Share by Types from 2014 to 2026

• Figure Chugoku Oncology Cancer Drugs Consumption Share by Types in 2014

• Figure Chugoku Oncology Cancer Drugs Consumption Share by Types in 2018

• Figure Chugoku Oncology Cancer Drugs Consumption Share by Types in 2026

• Table Chugoku Oncology Cancer Drugs Consumption by End-Users from 2014 to 2026

• Table Chugoku Oncology Cancer Drugs Consumption Share by End-Users from 2014 to 2026

• Figure Chugoku Oncology Cancer Drugs Consumption Share by End-Users in 2014

• Figure Chugoku Oncology Cancer Drugs Consumption Share by End-Users in 2018

• Figure Chugoku Oncology Cancer Drugs Consumption Share by End-Users in 2026

• Table Shikoku Oncology Cancer Drugs Consumption by Types from 2014 to 2026

• Table Shikoku Oncology Cancer Drugs Consumption Share by Types from 2014 to 2026

• Figure Shikoku Oncology Cancer Drugs Consumption Share by Types in 2014

• Figure Shikoku Oncology Cancer Drugs Consumption Share by Types in 2018

• Figure Shikoku Oncology Cancer Drugs Consumption Share by Types in 2026

• Table Shikoku Oncology Cancer Drugs Consumption by End-Users from 2014 to 2026

• Table Shikoku Oncology Cancer Drugs Consumption Share by End-Users from 2014 to 2026

• Figure Shikoku Oncology Cancer Drugs Consumption Share by End-Users in 2014

• Figure Shikoku Oncology Cancer Drugs Consumption Share by End-Users in 2018

• Figure Shikoku Oncology Cancer Drugs Consumption Share by End-Users in 2026

• Table Kyushu Oncology Cancer Drugs Consumption by Types from 2014 to 2026

• Table Kyushu Oncology Cancer Drugs Consumption Share by Types from 2014 to 2026

• Figure Kyushu Oncology Cancer Drugs Consumption Share by Types in 2014

• Figure Kyushu Oncology Cancer Drugs Consumption Share by Types in 2018

• Figure Kyushu Oncology Cancer Drugs Consumption Share by Types in 2026

• Table Kyushu Oncology Cancer Drugs Consumption by End-Users from 2014 to 2026

• Table Kyushu Oncology Cancer Drugs Consumption Share by End-Users from 2014 to 2026

• Figure Kyushu Oncology Cancer Drugs Consumption Share by End-Users in 2014

• Figure Kyushu Oncology Cancer Drugs Consumption Share by End-Users in 2018

• Figure Kyushu Oncology Cancer Drugs Consumption Share by End-Users in 2026

• Table Company Profile and Development Status of Roche diagnostics

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche diagnostics

• Figure Sales and Growth Rate Analysis of Roche diagnostics

• Figure Revenue and Market Share Analysis of Roche diagnostics

• Table Product and Service Introduction of Roche diagnostics

• Table Company Profile and Development Status of GlaxoSmithKline

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

• Figure Sales and Growth Rate Analysis of GlaxoSmithKline

• Figure Revenue and Market Share Analysis of GlaxoSmithKline

• Table Product and Service Introduction of GlaxoSmithKline

• Table Company Profile and Development Status of Johnson & Johnson

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

• Figure Sales and Growth Rate Analysis of Johnson & Johnson

• Figure Revenue and Market Share Analysis of Johnson & Johnson

• Table Product and Service Introduction of Johnson & Johnson

• Table Company Profile and Development Status of Eli lilly

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli lilly

• Figure Sales and Growth Rate Analysis of Eli lilly

• Figure Revenue and Market Share Analysis of Eli lilly

• Table Product and Service Introduction of Eli lilly

• Table Company Profile and Development Status of Celgene

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene

• Figure Sales and Growth Rate Analysis of Celgene

• Figure Revenue and Market Share Analysis of Celgene

• Table Product and Service Introduction of Celgene

• Table Company Profile and Development Status of Novartis

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

• Figure Sales and Growth Rate Analysis of Novartis

• Figure Revenue and Market Share Analysis of Novartis

• Table Product and Service Introduction of Novartis

• Table Company Profile and Development Status of Sanofi

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

• Figure Sales and Growth Rate Analysis of Sanofi

• Figure Revenue and Market Share Analysis of Sanofi

• Table Product and Service Introduction of Sanofi

• Table Company Profile and Development Status of Merck

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

• Figure Sales and Growth Rate Analysis of Merck

• Figure Revenue and Market Share Analysis of Merck

• Table Product and Service Introduction of Merck

• Table Company Profile and Development Status of Pfizer & Co

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer & Co

• Figure Sales and Growth Rate Analysis of Pfizer & Co

• Figure Revenue and Market Share Analysis of Pfizer & Co

• Table Product and Service Introduction of Pfizer & Co

• Table Company Profile and Development Status of Celgene & Co.

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene & Co.

• Figure Sales and Growth Rate Analysis of Celgene & Co.

• Figure Revenue and Market Share Analysis of Celgene & Co.

• Table Product and Service Introduction of Celgene & Co.